Elmiron Oral Capsule 100Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Elmiron: Oral capsule (100mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_12703.JPG
Elmiron 100mg Cap
Janssen Pharmaceuticals, Inc, formerly Pricara, a Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc
Pill Identification: BNP 7600 BNP 7600 

What is this Medicine?

PENTOSAN (PEN toe san) is used to treat the bladder pain or discomfort caused by interstitial cystitis. This is a condition that causes inflammation of parts of the kidney.

CVS Pharmacy Patient Statistics for Elmiron: Oral capsule(100mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information
Select a Medication

Elmiron 100mg Capsule

NDC: 504580098
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Interstitial Cystitis

Storage Information
Store at room temperature (between 59 to 86 degrees F)
Elmiron 100mg Capsule
Drug Image file DrugItem_12703.JPG
Janssen Pharmaceuticals, Inc, formerly Pricara, a Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc
Pill Identification: BNP 7600 BNP 7600 
Shape: capsule
Color: white

Reported Side Effects for Elmiron 100mg Capsule

Inflamed Optic Nerve Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Sore Throat Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Itching Incidence:
<1.0%*
Severity: MILD
Onset: RAPID
Low Platelet Count Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Ringing In Ears Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Hives Incidence:
<1.0%*
Severity: MILD
Onset: RAPID
Low White Blood Cell Counts Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Vomiting Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Conjunctivitis Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Bruise Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Photosensitivity Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Bleeding In Eye Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Lazy Eye Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Anemia Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Decreased Appetite Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Inflamed Colon Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Constipation Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Shortness Of Breath Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Nose Bleed Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Throat Inflammation Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Gas Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Inflamed Stomach Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Lightheadedness Incidence:
1.0%*
Severity: MILD
Onset: EARLY
Elevated Hepatic Enzymes Incidence:
1.2%*
Severity: MODERATE
Onset: DELAYED
Stomach Pain Incidence:
2.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
2.0%*
Severity: MILD
Onset: EARLY
Headache Incidence:
3.0%*
Severity: MILD
Onset: EARLY
Skin Rash Incidence:
3.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
4.0%*
Severity: MILD
Onset: EARLY
Loose Stools Incidence:
4.0%*
Severity: MILD
Onset: EARLY
Hair Loss Incidence:
4.0%*
Severity: MILD
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

SECOND Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

THIRD Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Lactation

Compatible - This drug is generally safe to take by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Elmiron

We want to help you stay educated about the medications you are taking. View other
patient's observations and share your own.

Be sure to consult your health care provider before taking any medications. Other
patient's comments should not be considered medical advice or health care provider
recommendations.